http://www.pharmaasia.comPharmaAsia - Alliances and Mergersen-USCopyright 2012 Ten Alps Communications Asia. All rights reserved.Thu, 9 Feb 2012 19:23:22 +0800http://www.pharmaasia.com/article/docs-continues-expansion-with-four-new-offices-in-europe/9320ICON announced that its resourcing division, DOCS, has expanded in Europe by opening four new offices: in Milan, Italy; Budapest, Hungary; Brussels, Belgium and Berlin, Germany. This latest expansion brings the total number of DOCS offices in Europe to 22.http://www.pharmaasia.com/article/docs-continues-expansion-with-four-new-offices-in-europe/9320Fri, 3 Feb 2012 00:00:00 +0800http://www.pharmaasia.com/article/agilent-technologies-joins-sponsors-of-greencentre-canada/9307Agilent Technologies has joined the sponsors of GreenCentre Canada, a national centre of excellence for commercializing green chemistry discoveries generated by academic researchers and industry.http://www.pharmaasia.com/article/agilent-technologies-joins-sponsors-of-greencentre-canada/9307Mon, 30 Jan 2012 00:00:00 +0800http://www.pharmaasia.com/article/sartorius-stedim-biotech-refine-technology-announce-cooperation/9310This joint development project proactively responds to the current market demand for more effective connectivity between equipment from different suppliers to enable development of efficient, streamlined systems.http://www.pharmaasia.com/article/sartorius-stedim-biotech-refine-technology-announce-cooperation/9310Thu, 26 Jan 2012 00:00:00 +0800http://www.pharmaasia.com/article/phase-iii-studies-with-vegf-trap-eye-in-wet-age-related-macular-degeneration-show-sustained-improvement-in-visual-acuity/9306Bayer HealthCare and Regeneron Pharmaceuticals announced that in an integrated analysis of two parallel Phase III studies (VIEW 1 and VIEW 2) in patients with the neovascular form of age-related macular degeneration (wet AMD), patients treated with VEGF Trap-Eye showed a sustained improvement in visual acuity at 96 weeks versus baseline.http://www.pharmaasia.com/article/phase-iii-studies-with-vegf-trap-eye-in-wet-age-related-macular-degeneration-show-sustained-improvement-in-visual-acuity/9306Wed, 25 Jan 2012 00:00:00 +0800http://www.pharmaasia.com/article/agilent-technologies-integrated-diagnostics-enter-into-partnership/9301Agilent Technologies and Integrated Diagnostics announced a partnership to develop assays that detect major human diseases at very early stages to improve treatment outcomes.http://www.pharmaasia.com/article/agilent-technologies-integrated-diagnostics-enter-into-partnership/9301Mon, 16 Jan 2012 00:00:00 +0800http://www.pharmaasia.com/article/pbl-interferonsource-collaborates-with-avanza/9300PBL InterferonSource (PBL) and AVANZA Laboratories announced collaboration between their two organizations that will focus on enhancing their ability to service the biopharmaceutical industry.http://www.pharmaasia.com/article/pbl-interferonsource-collaborates-with-avanza/9300Fri, 13 Jan 2012 00:00:00 +0800http://www.pharmaasia.com/article/icon-acquires-beijingwits-medical-consulting/9299ICON has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting, a leading CRO in China. The transaction is expected to close in the first quarter of 2012.http://www.pharmaasia.com/article/icon-acquires-beijingwits-medical-consulting/9299Wed, 11 Jan 2012 00:00:00 +0800http://www.pharmaasia.com/article/agilent-technologies-and-oxford-gene-technology-expand-microarray-and-sequencing-partnership/9251OGT the first company to be awarded Agilent High-Throughput Microarray Certified Service Provider status.http://www.pharmaasia.com/article/agilent-technologies-and-oxford-gene-technology-expand-microarray-and-sequencing-partnership/9251Tue, 18 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/pharmaceutical-and-biotech-companies-boost-resources-in-medical-affairs-affiliates/9248Cutting Edge Information finds country-level medical affairs budgets now average $1.9 million.http://www.pharmaasia.com/article/pharmaceutical-and-biotech-companies-boost-resources-in-medical-affairs-affiliates/9248Tue, 18 Oct 2011 00:00:00 +0800http://www.pharmaasia.com/article/roche-signs-definitive-agreement-to-acquire-anadys-pharmaceuticals/9243A cquisition aims to expand future treatment options for hepatitis C patients.http://www.pharmaasia.com/article/roche-signs-definitive-agreement-to-acquire-anadys-pharmaceuticals/9243Mon, 17 Oct 2011 00:00:00 +0800